Madrasin decreases transcription of protein-coding genes. by Michael Tellier (8284752)

Shuffling identity decreases behavior trajectory uniqueness. by Catalin Mitelut (5587493)

Maximum IFN concentrations are decreased in severe patients. by Sonia T. Gazeau (21512764)

The Samn-Perelli Scale is a 7-point Likert scale used to assess fatigue [42, 45]. by Marcel F. Hinss (14675457)

Mean standard errors across time points for the outcome of social stigma. by Ana Beato (20489933)

Means with standard errors across time points for the outcome of social distance. by Ana Beato (20489933)

Means with standard errors across time points for the outcome of intergroup anxiety. by Ana Beato (20489933)

The reduced virulence of Δalta1 mutants is not primarily due to a decrease in growth. by Shuhuan Zhang (748003)

A summary of the included study characteristics. by Zahra Tajik (20752452)

Subjects:

Does a correlation exist between delayed vaccination and a decreased vaccine confidence? by Virginia Reverte (9046494)

“…Online questionnaire was sent to their parents, followed by a telephone questionnaire for non-responders. Regarding MMR first dose, a significant association was found between delay and birth order and intellectual/motor delay of children. …”

Mean (95% CI) and standard deviation of Co-Contraction index of right and left gluteus medius (MVC%) during 60 minutes standing between two groups. by Saeedeh Abbasi (9423189)

Subjects:

Post-mortem lesions of chickens with decreased egg production in Yancheng in 2023. by Yan Wang (15435)

Hypothesis 3: The mean difference between “Class 1” (a school attack happens within <i>k</i> kms. of a given school) and “Class 0” (no school attack happens within <i>k</i> kms. of... by Lirika Sola (21560710)

Voxel-based whole-brain analysis shows regional and dose-dependent effects of netoglitazone in decreasing plaque mean size. by Francesca Catto (21253435)

“…However, there is only a minimal effect on decreasing plaque size. (C) Short-term-treatment with a high dose of netoglitazone reveals a significant reduction in plaque size, especially observed in the hippocampus, striatum, thalamus, hypothalamus, midbrain, and hindbrain. …”

The body weight and cholesterol levels of the mice were recorded before the administration of the drug. by Xueqin lu (22250795)

Subjects:

Effects of Kylo-0603 on body weight, organ weight, and body fat content. by Xueqin lu (22250795)

Subjects:

After 8 weeks of treatment, body fat analysis and bone mineral density testing of mice in each group. by Xueqin lu (22250795)

Subjects:

Pharmacological efficacy of Kylo-0603 in MASH mouse models (F2 ~ 3). by Xueqin lu (22250795)

Subjects:

Plasma cholesterol and LDL-C levels. by Xueqin lu (22250795)

Subjects:

The Chol and TG content in liver homogenates of the mice in each group after 2 and 10 weeks of drug intervention. by Xueqin lu (22250795)

Subjects: